AV078

Asset

CNS-penetrant selective inhibition of mTORC1.

Stage: Phase 1
Modality: Small molecule
Target: Autophagy; 1
Indication: 1
Trial: 1
Developer

Indications

1

Tuberous sclerosis complex
Phase 1, aeovian.com, 7 Oct 2026

In the full profile

Targets and what it contains3
Owner and partners1
Trials1
Evidence for its targets3
Competitors1
Aging relevance2

Every asset’s record: target, stage, trials and the evidence behind it.